Fetal Penile Length and Corpus Cavernosum Length - Normal Measurement Via Ultrasound

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2010 by Tel-Aviv Sourasky Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier:
NCT01114867
First received: April 29, 2010
Last updated: March 26, 2014
Last verified: April 2010
  Purpose

Hypothesis: Measurement of fetal penis length by ultrasound may be inaccurate when measured from the scrotum to the penile tip. we will provide normal values of penile length measured from the penile tip to the abdominal wall and measuring the corpus cavernosum length.


Condition
Fetal Penis Length

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Prospective Cross-sectional Study of Fetal Penis and Corpus Cavernosum Length

Further study details as provided by Tel-Aviv Sourasky Medical Center:

Estimated Enrollment: 200
Study Start Date: October 2010
  Eligibility

Ages Eligible for Study:   14 Weeks to 34 Weeks
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Fetuses of healthy pregnant women

Criteria

Inclusion Criteria:

  • pregnant women at 14th through 34th week gestation,
  • routine ultrasound not preformed for anomalies at the genitourinary system,
  • estimated fetal weight corresponds to gestational age.

Exclusion Criteria:

  • women who's fetuses are suspected to be with fetal growth retardation,
  • women who's fetuses are suspected to be with genitourinary anomaly.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01114867

Locations
Israel
Ultrasound Unit in OBGYN, Soraski Medical Center Not yet recruiting
Tel-Aviv, Israel, 64239
Contact: Yoseph Hartoov, Dr    +972-3-6925747      
Contact: Arnon Agmon, Dr    +972-3-6925747    arnon@arnonagmon.com   
Principal Investigator: Yoseph Hartoov, Dr         
Sponsors and Collaborators
Tel-Aviv Sourasky Medical Center
Investigators
Principal Investigator: Yoseph Hartoov, Dr Tel-Aviv, Soraski Medical Center
  More Information

No publications provided

Responsible Party: Yoseph Hartoov / Dr, Sorasky Medical Center
ClinicalTrials.gov Identifier: NCT01114867     History of Changes
Other Study ID Numbers: TASMC-10-YH-0128-CTIL
Study First Received: April 29, 2010
Last Updated: March 26, 2014
Health Authority: Israel: Ministry of Health

Keywords provided by Tel-Aviv Sourasky Medical Center:
ultrasound
penis length
corpus cavernosum
length of fetal penis and fetal corpus cavernosum

ClinicalTrials.gov processed this record on July 22, 2014